Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration. [electronic resource]
Producer: 20140515Description: 825-833.e1 p. digitalISSN:- 1879-1891
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Bevacizumab
- Databases, Factual
- Drug Utilization -- statistics & numerical data
- Female
- Fluorescein Angiography
- Humans
- Insurance Claim Review
- Intravitreal Injections
- Male
- Medicare Part B
- Ranibizumab
- Retreatment
- Retrospective Studies
- Tomography, Optical Coherence
- Treatment Outcome
- United States
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
- Wet Macular Degeneration -- diagnosis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.